Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Feng-Jun Qiu"'
Autor:
Yi-Wei Zhu, Xiao-Feng Yan, Ting-Jie Ye, Jing Hu, Xiao-Ling Wang, Feng-Jun Qiu, Cheng-Hai Liu, Xu-Dong Hu
Publikováno v:
Journal of Traditional and Complementary Medicine, Vol 11, Iss 2, Pp 180-187 (2021)
Background and aim: Huashi Baidu Decoction (HSBD) is a novel complex prescription which has positive effects on severe COVID-19. This study was aimed to discover key Chinese materia medica, main active compounds, hub therapeutic target proteins and c
Externí odkaz:
https://doaj.org/article/082c5505e54d4abfba706627a7cbcc8a
Autor:
Shou-Mei Wang, Pei-Wei Yang, Xiao-Jun Feng, Yi-Wei Zhu, Feng-Jun Qiu, Xu-Dong Hu, Shu-Hui Zhang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundApigenin, as a natural flavonoid, has low intrinsic toxicity and has potential pharmacological effects against hepatocellular carcinoma (HCC). However, the molecular mechanisms involving microRNAs (miRNAs) and their target genes regulated b
Externí odkaz:
https://doaj.org/article/f88541bea74547e287e4102f60f4d118
Publikováno v:
Jisuanji kexue, Vol 48, Iss 11, Pp 226-233 (2021)
Existing object pose estimation methods cannot provide estimated poses with inter-frame stability.As a result,when the results are directly used in visualization scenarios such as augmented reality,it will cause screen jitter,so it's not suitable eno
Externí odkaz:
https://doaj.org/article/f81dfd8688e64b3bb40616e56f4ef7b9
Autor:
Yan-Lin Lu, Hua Li, Xiao-Feng Yan, Ting-Jie Ye, Wei Xu, Feng-Jun Qiu, Xiao-Ling Wang, Yi-Wei Zhu, Du Li, Xu-Dong Hu
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
Evidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
Background: Alcoholic fatty liver disease (AFLD) is the first stage of the alcoholic liver disease course. Yin-Chen-Hao-Tang (YCHT) has a good clinical effect on the treatment of AFLD, but its molecular mechanism has not been elucidated. In this stud
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 5, p e0250634 (2021)
PLoS ONE, Vol 16, Iss 5, p e0250634 (2021)
Background Drug resistance frequently led to the failure of chemotherapy for malignant cancers, hence causing cancer relapse. Thus, understanding mechanism of drug resistance in cancer is vital to improve the treatment efficacy. Here, we aim to evalu